Induction of cyclooxygenase-2 by lipopolysaccharide in canine tracheal smooth muscle cells:: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-κB pathways

被引:39
作者
Luo, SF
Wang, CC
Chien, CS
Hsiao, LD
Yang, CM
机构
[1] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan
[2] Chang Gung Univ, Coll Med, Dept Internal Med, Tao Yuan, Taiwan
关键词
Ca2+; inflammation; MEK1/2; phospholipase C; prostagladins; protein kinase C;
D O I
10.1016/S0898-6568(02)00135-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lipopolysaccharide (LPS) was found to induce inflammatory responses in the airways and exerted as a potent stimulus for PG synthesis. This study was to determine the mechanisms of LPS-enhanced cyclooxygenase (COX)-2 expression associated with PGE(2) Synthesis in tracheal smooth muscle cells (TSMCs). LPS markedly increased the expression of COX-2 and release of PGE(2) in a time- and concentration-dependent manner, whereas COX- I remained unaltered. Both the expression of COX-2 and the generation of PGE(2) in response to LPS were attenuated by a tyrosine kinase inhibitor genistein, a phosphatidylcholine-phospholipase C inhibitor D609, a phosphatidylinositol-phospholipase C inhibitor U73122, protein kinase C inhibitors, GF109203X and staurosporine, removal of Ca2+ by addition of BAPTA/AM plus EGTA, and phosphatidylinositol 3-kinase (PI3-K) inhibitors, LY294002 and wortmannin. Furthermore, LPS-induced NF-kappaB activation correlated with the degradation Of IkappaB-alpha, COX-2 expression, and PGE(2) synthesis, was inhibited by transfection with dominant negative mutants of NIK and IKK-alpha, but not by IKK-beta. LPS-induced COX-2 expression and PGE(2) Synthesis were completely inhibited by PD98059 (an inhibitor of MEK1/2) and SB203580 (an inhibitor of p38 MAPK inhibitor), but these two inhibitors had no effect on LPS-induced NF-kappaB activation, indicating that NF-kappaB is activated by LPS independently of activation of p42/p44 MAPK and p38 MAPK pathways in TSMCs. Taken together, these findings suggest that the increased expression of COX-2 correlates with the release of PGE(2) from LPS-challenged TSMCs, at least in part, independently mediated through MAPKs and NF-kappaB signalling pathways. LPS-mediated responses were modulated by PLC, Ca2+, PKC, tyrosine kinase, and PI3-K in these cells. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:497 / 509
页数:13
相关论文
共 50 条
[1]   WORTMANNIN IS A POTENT PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR - THE ROLE OF PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE IN NEUTROPHIL RESPONSES [J].
ARCARO, A ;
WYMANN, MP .
BIOCHEMICAL JOURNAL, 1993, 296 :297-301
[2]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[3]  
BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756
[4]   ENHANCEMENT OF THE ENDOTHELIAL PRODUCTION OF PROSTACYCLIN BY SUBSTITUTED DERIVATIVES OF BAPTA-AM [J].
BOEYNAEMS, JM ;
HEILPORN, S ;
BROEDERS, F ;
BRAEKMAN, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 233 (01) :13-20
[5]   Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1β in RAW264 macrophages [J].
Caivano, M ;
Cohen, P .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :3018-3025
[6]   Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity [J].
Chen, ZJ ;
Parent, L ;
Maniatis, T .
CELL, 1996, 84 (06) :853-862
[7]  
Cobb RR, 1996, MOL PHARMACOL, V49, P998
[8]  
COREY JL, 1994, J BIOL CHEM, V269, P14759
[9]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[10]  
DeWitt DL, 1999, MOL PHARMACOL, V55, P625